Year archive

STARSOURCE MULTITRADE LIMITED — 2024 filings

All 44 regulatory filings released by STARSOURCE MULTITRADE LIMITED (506365) in 2024, sourced directly from the official regulator.

44 Filings

2024 Period

2024 filings (44)

Filing	Released	Lang
Intimation for Appointment of Independent Director (Non-Executive) on the Board of Directors of the Company under Regulation 30 of SEBI (LODR) Regulations, 2015. Regulatory Filings	2024-12-31	English
Intimation of Trading Window Closure Regulatory Filings	2024-12-31	English
Submission of Newspaper Advertisement of Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2024. Regulatory Filings	2024-10-29	English
Approval of Un-Audited Financial Results for the Quarter and Half Year Ended September 30, 2024 along with Limited Review Report thereon. Regulatory Filings	2024-10-28	English
Approval of Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2024 along with the Limited Review Report thereon. Regulatory Filings	2024-10-28	English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 ,inter alia, to consider and approve the Un-Audited Financial .... Regulatory Filings	2024-10-15	English
Clarification sought as per provision to Regulation 30 SEBI (LODR) Regulation, 2015 Regulatory Filings	2024-10-14	English
Declaration of Non-Applicability of Regulation 23(9) of SEBI (LODR) Regulation, 2015 for the half year ended September 30, 2024 Regulatory Filings	2024-10-08	English
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter Ended September 30, 2024 Regulatory Filings	2024-10-01	English
Intimation of Trading Window Closure Regulatory Filings	2024-09-30	English
Voting Results and Consolidated Scrutinizer''s Report of the 82nd Annual General Meeting as per Regulation 44 of SEBI (LODR) Regulation, 2015 Regulatory Filings	2024-09-24	English
Proceeding of the 82nd Annual General Meeting Regulatory Filings	2024-09-23	English
Submission of Newspaper Advertisement for Notice of 82nd AGM, E-voting information and Book Closure published on August 30, 2024 in Business Standard (English) and Mumbai Lakshwadeep (Marathi). Regulatory Filings	2024-09-02	English
This is to inform that the 82nd Annual General Meeting of the Company schedule to be held on Monday, September 23, 2024 at 04:00 p.m. at the Registered Office of the Company at 5-Kumud .... Regulatory Filings	2024-08-26	English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (LODR) Regulations, 2015 Regulatory Filings	2024-08-19	English
Submission of Newspaper Advertisement of Unaudited Financial Results for the First Quarter Ended June 30, 2024 of the Company Regulatory Filings	2024-07-31	English
Intimation of Book Closure to the Regulation 42(2) to (4) of SEBI (LODR) Regulations, 2015 Regulatory Filings	2024-07-29	English
Approval of Un-Audited Financial Results of the Company for the Quarter Ended June 30, 2024 along with the Limited Review Report thereon Regulatory Filings	2024-07-29	English
1. Approval of Un-Audited Financial Results of the Company for the quarter ended June 30, 2024 along with the Limited Review Report thereon. 2. Approval of the Notice of the 82nd Annual .... Regulatory Filings	2024-07-29	English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2024 ,inter alia, to consider and approve the following business: 1. . Regulatory Filings	2024-07-09	English
Certificate under Regulation 74(5) of SEBI (DP), Regulations, 2018 for the Quarter Ended June 30, 2024 Regulatory Filings	2024-07-02	English
Intimation of Trading Window closure Regulatory Filings	2024-06-28	English
Intimation regarding issue of Duplicate Share Certificate under Reg. 39(3) of SEBI (LODR) Regulation, 2015 Regulatory Filings	2024-06-10	English
Submission of Newspaper Advertisement of Audited Financial Results for the Quarter and Year Ended March 31, 2024 of the Company Regulatory Filings	2024-05-28	English
Appointment of M/S Sarda Soni Associates LLP as an Internal Auditor for the Financial Year 2024-2025 Regulatory Filings	2024-05-27	English
Audited Financial Results of the Company for the Quarter and Year Ended March 31, 2024 Regulatory Filings	2024-05-27	English
Outcome Of The Board Meeting Held On Monday, May 27, 2024 Regulatory Filings	2024-05-27	English
Declaration of Non-Applicability of Regulation 23(9) of SEBI (LODR) Regulation, 2015 for the half year ended March 31, 2024 Regulatory Filings	2024-05-15	English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 ,inter alia, to consider and approve the following business: 1. . Regulatory Filings	2024-05-10	English
Intimation regarding issue of Dublicate Share Certificate under Regulation 39(3) of SEBI (LODR) Regulations, 2015 Regulatory Filings	2024-05-07	English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (LODR) Regulation, 2015 Regulatory Filings	2024-04-23	English
We hereby submit Compliance Certificate under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the year ended March 31, 2024. Regulatory Filings	2024-04-11	English
Non-Applicability of Annual Secretarial Compliance Report for the year ended March 31, 2024, under Regulation 24A of SEBI (LODR)Regulations, 2015. Regulatory Filings	2024-04-05	English
Compliance Certificate Pursuant to Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the Financial Year Ended 31st March 2024. Regulatory Filings	2024-04-05	English
Declaration of Non-applicability of Regulation 23(9) of SEBI (LODR) Regulations, 2015 for the half year ended March 31, 2024. Regulatory Filings	2024-04-02	English
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the Quarter Ended March 31, 2024 Regulatory Filings	2024-04-02	English
Intimation of Trading Window closure Regulatory Filings	2024-03-28	English
Submission of Newspaper Advertisement of Unaudited Financial Results for the Quarter and Nine Months Ended December 31, 2023. Regulatory Filings	2024-01-30	English
Appointment of M/s Kavita Khatri & Associates Company Secretary as the Secretarial Auditor of the Company for the Financial Year 2023-24 Regulatory Filings	2024-01-29	English
Approval the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2023 along with the Limited Review Report thereon. Regulatory Filings	2024-01-29	English
1. Approval the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2023 along with the Limited Review Report thereon. 2. Approved the .... Regulatory Filings	2024-01-29	English
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 ,inter alia, to consider and approve 1. the Un-Audited .... Regulatory Filings	2024-01-09	English
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (LODR) Regulation, 2015 Regulatory Filings	2024-01-05	English
Compliance Certificate under Reg.74(5) of SEBI (DP) Regulations, 2018 for the Quarter Ended December 31, 2023. Regulatory Filings	2024-01-02	English

Filings by year

2026 12 filings
2025 80 filings
2024 44 filings
2023 46 filings
2022 40 filings
2021 31 filings
2020 33 filings
2019 32 filings